Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types.
Journal article
Rao SR. et al, (2023), Int J Mol Sci, 24
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?
Journal article
Cussenot O. et al, (2023), BJU Int
Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique.
Journal article
Bryant RJ. et al, (2023), BJU Int, 131, 694 - 704
Re: Fifteen-year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
Journal article
Sharma AD. et al, (2023), Eur Urol
Comparison of traditional outcome measures and self-assessed goal achievement in patients treated surgically for benign prostatic hyperplasia.
Journal article
Pratsinis M. et al, (2023), World J Urol, 41, 1125 - 1131
The Detection of Prostate Cancer With Magnetic Resonance Imaging-targeted Prostate Biopsies Is Superior With the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study. Letter
Journal article
Bryant RJ. et al, (2023), Journal of Urology, 209
Total pelvic exenteration surgery for loco-regionally advanced prostate cancer, is it justifiable?
Journal article
Cussenot O. et al, (2022), BJU International, 130, 582 - 585
Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones.
Journal article
Marklund M. et al, (2022), Nat Commun, 13
Spatially resolved clonal copy number alterations in benign and malignant tissue.
Journal article
Erickson A. et al, (2022), Nature, 608, 360 - 367
The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters.
Journal article
Rakovic K. et al, (2022), Diagnostics (Basel), 12
Re: Prostate Cancer Screening Using a Combination of Risk-prediction, MRI, and Targeted Prostate Biopsies (STHLM3-MRI): A Prospective, Population-based, Randomised, Open-label, Non-inferiority Trial.
Journal article
Raslan M. et al, (2022), Eur Urol, 81, 543 - 544
The provision of prostate cancer patient information leaflets on an electronic tablet: A further step to paperless health-care provision
Journal article
Miah S. et al, (2022), Urology Annals, 14, 156 - 161
Genomic sequencing in oncology: Considerations for integration in routine cancer care
Journal article
Rahman B. et al, (2022), European Journal of Cancer Care
Morphological Features Extracted by AI Associated with Spatial Transcriptomics in Prostate Cancer.
Journal article
Chelebian E. et al, (2021), Cancers (Basel), 13
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse.
Journal article
Taavitsainen S. et al, (2021), Nat Commun, 12
Local anaesthetic transperineal (LATP) prostate biopsy using a probe-mounted transperineal access system: a multicentre prospective outcome analysis.
Journal article
Lopez JF. et al, (2021), BJU Int, 128, 311 - 318
Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer.
Journal article
Sjoberg HT. et al, (2021), Br J Cancer, 125, 534 - 546
Risks and Benefits of Live Surgical Broadcast: A Systematic Review.
Journal article
Carbonara U. et al, (2021), Eur Urol Focus
A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease.
Journal article
Erickson A. et al, (2021), Eur Urol Oncol, 4, 358 - 369